Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Catalysts towards cancer risk management action: A longitudinal study of reproductive-aged women with BRCA1/2 mutations.

Journal of psychosocial oncology - 1 Jan 2000

Werner-Lin Allison, Ersig Anne L, Mueller Rebecca, Young Jennifer L, Hoskins Lindsey M, Desai Ria, Greene Mark H

Abstract excerpt

Deleterious mutations in BRCA1 or BRCA2 genes increase a woman's lifetime risk of breast and ovarian cancer. Risk management guidelines endorse early detection and prevention behaviors. Despite expressed intent, uptake of these measures remains low. This longitudinal, qualitative study integrated retrospective and prospective data to distinguish factors shaping intent to act from those that are catalysts to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Neoplasms
Share to Genes, BRCA1

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Genes, BRCA2

Share to Genetic Testing

Share to Longitudinal Studies

Share to Ovarian Neoplasms

Share to Qualitative Research

Share to Risk Reduction Behavior

Source

Identifiers

PMID: 29863445
DOI: 10.1080/07347332.2018.1469565

Genes

BRCA1
BRCA2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Catalysts towards cancer risk management action: A longitudinal study of reproductive-aged women with BRCA1/2 mutations.PMID 29863445Read ↗

Longitudinal cancer risk management trajectories of BRCA1/2 mutation-positive reproductive-age women.Semantic proximity Read ↗

Involvement and Influence of Healthcare Providers, Family Members, and Other Mutation Carriers in the Cancer Risk Management Decision-Making Process of BRCA1 and BRCA2 Mutation Carriers.Semantic proximity Read ↗

In their own words: treating very young BRCA1/2 mutation-positive women with care and caution.Semantic proximity Read ↗

Preserving the self: the process of decision making about hereditary breast cancer and ovarian cancer risk reduction.Semantic proximity Read ↗

Cancer risk management decision making for BRCA+ women.Semantic proximity Read ↗

Investigating men's motivations to engage in genetic screening for BRCA1 and BRCA2 mutations.Semantic proximity Read ↗

Predictors of risk-reducing surgery intentions following genetic counseling for hereditary breast and ovarian cancer.Semantic proximity Read ↗

Life trajectories, genetic testing, and risk reduction decisions in 18-39 year old women at risk for hereditary breast and ovarian cancer.Semantic proximity Read ↗

Seeking balance: decision support needs of women without cancer and a deleterious BRCA1 or BRCA2 mutation.Semantic proximity Read ↗

Living a Cancer Surveillance Life: A Meta-Ethnographic Synthesis of Everyday Experiences and Ambivalences for Women Living With Hereditary Risk of Breast and/or Ovarian Cancer.Semantic proximity Read ↗

A multi-case report of the pathways to and through genetic testing and cancer risk management for BRCA mutation-positive women aged 18-25.Semantic proximity Read ↗

Mammography decision making in older women with a breast cancer family history.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.